225 related articles for article (PubMed ID: 29162879)
1. MiR-30e inhibits tumor growth and chemoresistance via targeting IRS1 in Breast Cancer.
Liu MM; Li Z; Han XD; Shi JH; Tu DY; Song W; Zhang J; Qiu XL; Ren Y; Zhen LL
Sci Rep; 2017 Nov; 7(1):15929. PubMed ID: 29162879
[TBL] [Abstract][Full Text] [Related]
2. Downregulation of miR-145 associated with cancer progression and VEGF transcriptional activation by targeting N-RAS and IRS1.
Yin Y; Yan ZP; Lu NN; Xu Q; He J; Qian X; Yu J; Guan X; Jiang BH; Liu LZ
Biochim Biophys Acta; 2013 Feb; 1829(2):239-47. PubMed ID: 23201159
[TBL] [Abstract][Full Text] [Related]
3. Overexpression of microRNA-190 inhibits migration, invasion, epithelial-mesenchymal transition, and angiogenesis through suppression of protein kinase B-extracellular signal-regulated kinase signaling pathway via binding to stanniocalicin 2 in breast cancer.
Sun G; Liu M; Han H
J Cell Physiol; 2019 Aug; 234(10):17824-17838. PubMed ID: 30993707
[TBL] [Abstract][Full Text] [Related]
4. miRNA-205 targets VEGFA and FGF2 and regulates resistance to chemotherapeutics in breast cancer.
Hu Y; Qiu Y; Yagüe E; Ji W; Liu J; Zhang J
Cell Death Dis; 2016 Jun; 7(6):e2291. PubMed ID: 27362808
[TBL] [Abstract][Full Text] [Related]
5. FoxP3-miR-150-5p/3p suppresses ovarian tumorigenesis via an IGF1R/IRS1 pathway feedback loop.
Zhang Q; Zhou X; Wan M; Zeng X; Luo J; Xu Y; Ji L; Zhang JA; Fan P; Zhong J; Wu J
Cell Death Dis; 2021 Mar; 12(3):275. PubMed ID: 33723215
[TBL] [Abstract][Full Text] [Related]
6. A regulatory circuit of miR-148a/152 and DNMT1 in modulating cell transformation and tumor angiogenesis through IGF-IR and IRS1.
Xu Q; Jiang Y; Yin Y; Li Q; He J; Jing Y; Qi YT; Xu Q; Li W; Lu B; Peiper SS; Jiang BH; Liu LZ
J Mol Cell Biol; 2013 Feb; 5(1):3-13. PubMed ID: 22935141
[TBL] [Abstract][Full Text] [Related]
7. MicroRNA-424-5p enhances chemosensitivity of breast cancer cells to Taxol and regulates cell cycle, apoptosis, and proliferation.
Dastmalchi N; Safaralizadeh R; Hosseinpourfeizi MA; Baradaran B; Khojasteh SMB
Mol Biol Rep; 2021 Feb; 48(2):1345-1357. PubMed ID: 33555529
[TBL] [Abstract][Full Text] [Related]
8. miR-126 reduces trastuzumab resistance by targeting PIK3R2 and regulating AKT/mTOR pathway in breast cancer cells.
Fu R; Tong JS
J Cell Mol Med; 2020 Jul; 24(13):7600-7608. PubMed ID: 32410348
[TBL] [Abstract][Full Text] [Related]
9. Suppression of SPIN1-mediated PI3K-Akt pathway by miR-489 increases chemosensitivity in breast cancer.
Chen X; Wang YW; Xing AY; Xiang S; Shi DB; Liu L; Li YX; Gao P
J Pathol; 2016 Aug; 239(4):459-72. PubMed ID: 27171498
[TBL] [Abstract][Full Text] [Related]
10. NT21MP negatively regulates paclitaxel-resistant cells by targeting miR‑155‑3p and miR‑155-5p via the CXCR4 pathway in breast cancer.
Wang Y; Yan L; Zhang L; Xu H; Chen T; Li Y; Wang H; Chen S; Wang W; Chen C; Yang Q
Int J Oncol; 2018 Sep; 53(3):1043-1054. PubMed ID: 30015868
[TBL] [Abstract][Full Text] [Related]
11. Estrogen regulates miRNA expression: implication of estrogen receptor and miR-124/AKT2 in tumor growth and angiogenesis.
Jiang CF; Li DM; Shi ZM; Wang L; Liu MM; Ge X; Liu X; Qian YC; Wen YY; Zhen LL; Lin J; Liu LZ; Jiang BH
Oncotarget; 2016 Jun; 7(24):36940-36955. PubMed ID: 27175587
[TBL] [Abstract][Full Text] [Related]
12. MicroRNA-1271 inhibits the progression of papillary thyroid carcinoma by targeting IRS1 and inactivating AKT pathway.
Chen Y; Hao SA; Jiang Y; Gao B; Tian WG; Zhang S; Guo LJ; Wang LL; Luo DL
Eur Rev Med Pharmacol Sci; 2019 Sep; 23(18):7989-7999. PubMed ID: 31599424
[TBL] [Abstract][Full Text] [Related]
13. The microRNA-141-3p/ CDK8 pathway regulates the chemosensitivity of breast cancer cells to trastuzumab.
Song W; Wu S; Wu Q; Zhou L; Yu L; Zhu B; Gong X
J Cell Biochem; 2019 Aug; 120(8):14095-14106. PubMed ID: 31087707
[TBL] [Abstract][Full Text] [Related]
14. miR-195 inhibits tumor growth and angiogenesis through modulating IRS1 in breast cancer.
Wang Y; Zhang X; Zou C; Kung HF; Lin MC; Dress A; Wardle F; Jiang BH; Lai L
Biomed Pharmacother; 2016 May; 80():95-101. PubMed ID: 27133044
[TBL] [Abstract][Full Text] [Related]
15. Down-regulation of miR-9 promotes epithelial mesenchymal transition via regulating anoctamin-1 (ANO1) in CRC cells.
Park YR; Lee ST; Kim SL; Zhu SM; Lee MR; Kim SH; Kim IH; Lee SO; Seo SY; Kim SW
Cancer Genet; 2019 Feb; 231-232():22-31. PubMed ID: 30803553
[TBL] [Abstract][Full Text] [Related]
16. MiR-93 suppresses tumorigenesis and enhances chemosensitivity of breast cancer via dual targeting E2F1 and CCND1.
Bao C; Chen J; Chen D; Lu Y; Lou W; Ding B; Xu L; Fan W
Cell Death Dis; 2020 Aug; 11(8):618. PubMed ID: 32796817
[TBL] [Abstract][Full Text] [Related]
17. Downregulation of microRNA-205 inhibits cell invasion and angiogenesis of cervical cancer through TSLC1-mediated Akt signaling pathway.
Zhang F; Liu J; Xie BB
J Cell Physiol; 2019 Aug; 234(10):18626-18638. PubMed ID: 31049956
[TBL] [Abstract][Full Text] [Related]
18. MicroRNA-664 Targets Insulin Receptor Substrate 1 to Suppress Cell Proliferation and Invasion in Breast Cancer.
Wu L; Li Y; Li J; Ma D
Oncol Res; 2019 Mar; 27(4):459-467. PubMed ID: 29495974
[TBL] [Abstract][Full Text] [Related]
19. MicroRNA-22 Suppresses Breast Cancer Cell Growth and Increases Paclitaxel Sensitivity by Targeting NRAS.
Song YK; Wang Y; Wen YY; Zhao P; Bian ZJ
Technol Cancer Res Treat; 2018 Jan; 17():1533033818809997. PubMed ID: 30384806
[TBL] [Abstract][Full Text] [Related]
20. Demethylzeylasteral inhibits glioma growth by regulating the miR-30e-5p/MYBL2 axis.
Zhang K; Fu G; Pan G; Li C; Shen L; Hu R; Zhu S; Chen Y; Cui H
Cell Death Dis; 2018 Oct; 9(10):1035. PubMed ID: 30305611
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
